1.Presence of circulating autoantibodies against bronchial epithelia cell in patients with nonatopic asthma.
Dong Ho NAHM ; Hyunee YIM ; Hyun Joo LEE ; Eui Jin YIM ; Eun Ah CHOI ; Sun Sin KIM ; Soo Keol LEE ; Hae Sim PARK
Journal of Korean Medical Science 2000;15(6):631-634
Allergic response to common environmental agents has been regarded as a main pathogenetic mechanism of bronchial asthma. However, allergic sensitization (atopy) can not be detected in a siginificant number of adult asthmatic patients. The etiology of nonatopic asthma has not yet been defined. To evaluate the possible involvement of autoimmune response against bronchial mucosa in the pathogenesis of nonatopic asthma, we performed indirect immunofluorescence staining of fresh frozen human bronchial mucosa tissue using serum samples from patients with atopic and nonatopic asthma, healthy controls, and patients with systemic lupus erythematosus. On immunostaining, circulating IgG autoantibodies against bronchial mucosa were detected in 2 (9.1%) of 22 patients with nonatopic asthma and in none of 22 patients with atopic asthma and of 22 healthy controls. IgG autoantibodies from the two patients with nonatopic asthma predominantly stained the cytoplasmic membrane of basal cells in bronchial epithelium. Serum samples from 10 patients with systemic lupus erythematosus immunostained the nucleus of epithelial cells in whole layer of bronchial epithelium. This study showed the presence of circulating IgG autoantibodies against the bronchial epithelial cell in a small portion of patients with nonatopic asthma. Further studies may be necessary to evaluate the possible involvement of autoimmune mechanism in the pathogenesis of nonatopic asthma.
Asthma/immunology*
;
Autoantibodies/immunology*
;
Autoantibodies/blood
;
Bronchi/immunology*
;
Epithelial Cells/immunology
;
Human
;
Immunity, Mucosal/immunology
;
Respiratory Mucosa/immunology*
2.Leucine-rich Glioma-inactivated Protein 1 Antibody-associated Encephalitis:Report of Two Cases.
Acta Academiae Medicinae Sinicae 2019;41(5):714-718
Leucine-rich glioma-inactivated protein 1(LGI1)antibody-associated encephalitis is an autoimmune brain disease mainly seen in mid-aged and elderly people.Its main clinical manifestations include abnormal mental behaviors,facial-arm dystonia,hyponatremia,and hypokalemia.Immunotherapy with gamma globulin and/or hormone is effective.Two patients with LGT1 antibody-associated encephalitis were diagnosed in our center between January 2018 and October 2018,with typical clinical findings.The disease was cursed after immunoglobulin and hormone treatments.
Autoantibodies
;
immunology
;
Encephalitis
;
diagnosis
;
therapy
;
Humans
;
Proteins
;
immunology
3.Study on the clonal characteristics of idiopathic thrombocytopenic purpura-review.
Journal of Experimental Hematology 2004;12(4):538-541
The autoantigenic epitopes carried by the platelet glycoprotein in patients with idiopathic thrombocytopenic purpura (ITP) have been observed to localize on the specific regions of glycoprotein. There is a limited number of autoantigenic epitopes on the respective glycoproteins. The clonal B-cell and/or T cell expansion have been detected in some patients with ITP, and the autoantibodies is clonally derived. This research is of clinical importance since identification of clonally derived autoantibodies not only may help to discover the pathogenesis of ITP but also lead to less toxic and more specific therapies. In this review, the clonal limitation of autoantibody and clonal expansion of B-lymphocyte is ITP, clonal characteristics of T-lymphocyte in ITP, and significance of research on clones in ITP were discussed and summarized.
Autoantibodies
;
immunology
;
B-Lymphocytes
;
immunology
;
Epitopes
;
Humans
;
Purpura, Thrombocytopenic, Idiopathic
;
etiology
;
immunology
;
T-Lymphocytes
;
immunology
4.New insights into the immunopathogenesis of systemic lupus erythematosus: the role of T follicular helper cells.
Huijuan MA ; Suigui WAN ; Changqing XIA
Chinese Medical Journal 2014;127(19):3496-3502
OBJECTIVETo review the development of T follicular helper (TFH) cells and their role in systemic lupus erythematosus (SLE) pathogenesis, the effect of dendritic cells (DCs) on TFH cells in SLE, as well as the potential use of TFH cells as a new therapeutic target in clinical practice.
DATA SOURCESThe data used in this review were retrieved mainly from the PubMed database (1989-2013). The terms used in the literature search were "T follicular helper cells," "systemic lupus erythematosus," and "dendritic cells."
STUDY SELECTIONRelevant publications about the TFH cells development, the interaction between the TFH cells and the DCs, and the clinical applications of TFH cells were identified, retrieved, and reviewed.
RESULTSTFH cells, a novel distinct CD4+ T cell subset, are specialized in providing help to B cells in the formation of germinal centers (GCs) and long-term protective humoral immune responses. The development of TFH cells from naïve CD4+ T cell is a multistep process. As the pivot of immunoregulation, DCs are indispensable for TFH cells generation. In addition to receptor-ligand interactions between TFH cells and DCs, the cytokines secreted by DCs are also necessary for TFH cell generation. TFH cell dysregulation has been implicated in the development of SLE. More evidence from animal models of SLE and SLE patients suggests that TFH cells are necessary for pathogenic autoantibody production. Therefore, therapeutically targeting TFH cells can be a promising approach to treat antibody-mediated autoimmune diseases including SLE.
CONCLUSIONTFH cells play a critical role in the pathogenesis of SLE, making them attractive therapeutic targets in clinical practice.
Autoantibodies ; immunology ; Dendritic Cells ; immunology ; Humans ; Lupus Erythematosus, Systemic ; immunology ; T-Lymphocytes, Helper-Inducer ; immunology
6.Progress of pathogenesis and clinical treatment of Hashimoto's thyroiditis.
Qing GAO ; Li-Xin JIAN ; Jin-Guo XU ; Wen-Lin LI ; Zhi-Wei JIAN ; Su-Hua PAN
China Journal of Chinese Materia Medica 2012;37(20):3003-3006
Hashimoto's thyroiditis (HT) is a autoimmune disease that is highly incident year by year. Its clinical manifestations are alternative hyperthyroidism or hypothyroidism, relatively high Th1, excessively low Th2 and constantly increasing TGAb and TMAB. Currently, the disease is still difficult to be cured, and instable thyroid function makes it harder to be treated. Therefore, this essay makes a summary analysis on domestic and foreign studies on HT's pathogenesis, clinical manifestations and treatment, resulting that pure supplement or immunosuppressive therapy is hard to achieve notable efficacy, while existing traditional Chinese medicines could only mitigate clinical symposiums but did not reduce inflammation. Therefore, to look for methods and drugs for adjusting immunity imbalance by decreasing Th1 cell factors and increasing Th2 cell factors is significant to HT treatment to some extent.
Animals
;
Autoantibodies
;
immunology
;
Female
;
Humans
;
T-Lymphocytes, Helper-Inducer
;
immunology
;
Thyroiditis, Autoimmune
;
drug therapy
;
immunology
;
pathology
7.Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.
Seung Kyung HANN ; Jung Bin KIM
Yonsei Medical Journal 1995;36(5):457-461
Vitiligo is a disease in which melanocytes are selectively destroyed. The disease is thought to be an autoimmune process being there are antibodies to pigment cells in the sera of patients and animals with vitiligo. In the present study, sera from vitiligo patients were examined for reactivity with the human melanoma cell line, SK-Mel-28, by Western blot analysis of solubilized membrane antigens of these cells to identify the pigment cell antigens defined by antibodies in the patients with vitiligo. Antibody reactivity to human melanoma cells (SK-Mel-28) was investigated in 14 patients with vitiligo, and 16 with normal control individuals. Antibodies to the 116-113, 60, 40 KD antigens were associated with vitiligo being present in 79%, 86%, and 43% respectively of the patients with vitiligo, but in only 6%, 38% and 6% of the normal controls. In contrast, antibodies to the 160-155, 78 and 64 KD antigens were equally common in vitiligo and in normal individuals. The results suggest that autoreactivity to pigment cells occurs more commonly in patients with vitiligo than in the normal control and high autoreactivity to pigment cells in the vitiligo sera might be an impertinent epiphemenon to destroyed pigment cell.
Antibodies, Neoplasm/*blood
;
Antigens, Neoplasm/immunology
;
Autoantibodies/blood
;
Blotting, Western
;
Human
;
Melanoma/*immunology
;
Vitiligo/*immunology
8.Advances in Autoantibodies against C-reactive Protein in Systemic Lupus Erythematosus.
Acta Academiae Medicinae Sinicae 2019;41(5):678-684
Systemic lupus erythematosus(SLE)is a chronic autoimmune disease that involves multiple organs and tissues.Its pathogenic mechanism remains unclear.Impaired inflammatory response and reduced clearance of immune cells are key events in the development of SLE,during which the pentraxin family plays an important role.This article summarizes recent advances in the relationship between anti-C-reactive protein autoantibody and SLE.
Autoantibodies
;
immunology
;
C-Reactive Protein
;
immunology
;
Humans
;
Lupus Erythematosus, Systemic
;
immunology
9.Pathogenicity of antibody subtypes against pemphigus vulgaris antigen extracellular 1-2 epitopes.
Meng PAN ; Yun ZHOU ; Yi-Cheng WANG ; Wei-Ping LI ; Jie ZHENG
Acta Academiae Medicinae Sinicae 2007;29(2):186-190
OBJECTIVETo explore whether the antibody subtypes against the extracellular 1-2 (EC1-2) epitopes of pemphigus vulgaris antigen (PVA) are related to the pathogenesis of PVA.
METHODSEC1-2 fusion protein, emulsified with complete Freund's adjuvant (CFA) or aluminum hydroxide hydrate [Al ( OH)3], was used to immunize C57BL/6 mouse. After immunization, the cytokine types, specific antibody titers, and antibody subtypes were detected. Also, a neonatal mice model was used to evaluate the pathogenesis of different antibodies.
RESULTSTh1 type cytokine interferon gamma (IFNgamma) was elevated in CFA group, while Th 2 type cytokine interleukin-4 (IL-4) was increased in Al (OH)3 group. The antibody subtypes were different in both groups. After the two groups were transferred with antisera separately, the neonatal mice developed erosion on the skin from Al(OH)3 group, with acantholysis histopathologically and bright immuno-fluorescence deposition, which was not seen in CFA group.
CONCLUSIONDifferent antibody subtypes may contribute to the pathogenesis of disease.
Animals ; Antibody Specificity ; Autoantibodies ; immunology ; Desmoglein 3 ; immunology ; Epitopes ; immunology ; Mice ; Mice, Inbred C57BL ; Pemphigus ; immunology ; pathology
10.Screening and identification of auto-antigen RHDAG1 of rheumatic heart disease.
Jin-xiu MENG ; Yun-xiong LI ; Ping ZHU ; Ling LI ; Cong LU ; Shao-yi ZHENG ; Guang-hua LI ; Xi-yong YU
Journal of Southern Medical University 2011;31(7):1154-1158
OBJECTIVETo identify the candidate auto-antigen of rheumatic heart disease as a molecular marker for this disease.
METHODSThe total RNA of the heart tissue of patients with rheumatic heart disease was extracted and reverse-transcribed into long cDNA to construct the phage expression library. The library was screened using the serum from patients with active rheumatic fever, and the positive clone was identified and analyzed by bioinformatics and expressed in vitro. The expressed products were evaluated with Western blotting and its cross-reactivity was assessed.
RESULTSThe phage expression library of the heart tissue of patients with rheumatic heart disease was constructed, with the titer of the primary library of 3.3×10(6) pfu/ml, recombinant rate of 99%, and 81% of the inserted segments were larger than 1 kb. An auto-antigen RHDAG1 was identified by screening, which was homologous to keratin 18. RHDAG1 was detected in the serum of patients with active rheumatic fever and of those with rheumatic heart disease, but not in the serum of healthy subjects.
CONCLUSIONPhage display library can be an effective strategy to screen the auto-antigens of rheumatic heart disease. The auto-antigen RHDAG1 can be a candidate molecular biomarker of rheumatic heart disease and/or rheumatic fever.
Autoantibodies ; blood ; immunology ; Autoantigens ; immunology ; isolation & purification ; Autoimmune Diseases ; blood ; immunology ; Humans ; Peptide Library ; Rheumatic Heart Disease ; immunology